MtDNA gene mutations in ChRCC all involved complex I of the electron transport chain, in particular in the NADH dehydrogenase 5 gene (MT-ND5, in 6 of our 61 cases); due to the type of mutations observed, these would be likely to result in loss of complex I activity. This evidence concerns the gene MT-ND5 and chromophobe renal cell carcinoma.